Navigation Links
Whole-body MRI Takes Less Than 20 Min To Scan A Patient's Entire Body For Cancer Spread To Bone

Whole-body MRI with an automatic moving table is effective for evaluating the entire skeleton in patients with suspected bone metastasis (cancer that has spread to the bone from other parts of the body) in a single imaging scan-and it only takes between 15 and 18 minutes, say two different European studies.

For one study, researchers from the Clinica Girona in Catalonia, Spain, performed whole-body MRI on 42 patients with known malignant tumors and a suspicion of bone lesions. Upon analyzing the results, the researchers found that whole-body MRI had a sensitivity of 100%, a specificity of 95% and an accuracy of 97%. According to the researchers, these results were about 20% better than bone scintigraphy, which is usually performed for this purpose.

“Whole-body MRI is a relatively new technique that uses an automatic moving table and fast software. It offers a better sensitivity and higher specificity in detecting bone metastasis than other methods,?said Joan C. Vilanova, MD, lead researcher for the study.

In addition to all its benefits, say the researchers, whole-body MRI is not just limited to finding metastasis in the bone. “Besides its accuracy, quickness and the fact that it’s an MRI scan—which means it’s noninvasive and there is no radiation risk to the patient—whole-body MRI can also detect metastases in other parts of the body besides the bones, such as in the brain, lung or liver,?said Dr. Vilanova.

Dr. Vilanova will present the full results of the study on May 16 during the American Roentgen Ray Society Annual Meeting in New Orleans, LA.

In a separate study that compared the results of whole-body MRI and whole-body FDG-PET for detecting cancer, researchers from the University Hospital in Freiburg, Germany, also found that whole-body MRI is fast and accurate for discovering bone metastases. However, they discovered that whole-body FDG-PET is superior to whole-body MRI in for staging lymph nodes, soft-tissue tumors and metastasis in the internal organs.

For that study, the researchers scanned 120 patients using both whole-body MRI and whole-body FDG-PET. Similar to the Italian study, the whole-body MRI procedure took about 15 minutes total room time. They found that whole-body MRI detected 35 bone metastases, whereas whole-body FDG-PET discovered only 26. But MRI could only detect 63 of 68 lymph nodes, 15 of 19 soft-tissue tumors and 23 of 28 metastases in the internal organs, numbers below the detection rate of FDG-PET.

“In our experience, the combination of these two methods is the future in primary and recurrent tumor detection and staging,?said Nadir Ghanem, MD, lead researcher on the German study.

Dr. Ghanem will present the full results of the study on May 17 during the American Roentgen Ray Society Annual Meeting in New Orleans, LA.


'"/>

Source:American Roentgen Ray Society


Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Jump-starting T Cells In Skin Cancer
3. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Breakthrough Microarray-based Technology for the Study of Cancer
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
8. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
9. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
10. New Breast Cancer Test Could Save Lives
11. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
(Date:1/12/2017)... , Jan. 12, 2017  New research undertaken by ... of the future.  1,000 participants were simply asked which office ... which we may consider standard issue.  Insights on what ... were also gathered from futurists and industry leaders including ... James Canton .  Some of these ...
(Date:1/6/2017)... 6, 2017  Privately-held CalciMedica, Inc., announced that ... volunteers of a novel calcium release-activated calcium (CRAC) ... Acute pancreatitis, sudden painful inflammation ... but can be very serious.  In severe cases it ... extended hospital stays, time in the ICU and ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017 Bioptix, ... the "Company"), announced that on January 14, 2017 the ... under which the Company will terminate certain employees associated ... Diagnostics, Inc.  The Company commenced terminations on January 16, ... 30 days.  The Company may pay severance benefits in ...
(Date:1/21/2017)... 2017   Boston Biomedical , an industry leader ... cancer stemness pathways, today presented data from two clinical ... 2017 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers ... In a Phase Ib/II study of napabucasin ... cancer stemness pathways by targeting STAT3 – colorectal cancer ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... how current market conditions have influenced the most recent ... Regulus Therapeutics Inc. (NASDAQ: RGLS ), Abeona ... Inc. (NASDAQ: TBPH ), and Sage Therapeutics ... new research report by Grand View Research, global Biotech market size ...
(Date:1/20/2017)... January 20, 2017 http://www.Financialbuzz.com ... one of leading causes of death worldwide. There were ... number of cancer related deaths increased gradually over time, ... incidence rate of various cancers continues to drive demand ... report by Global Market Insights, Inc. cancer biological therapy ...
Breaking Biology Technology: